Our professionals

Imagen del Dr. Eduardo Castañón Álvarez. Oncología Médica de la Clínica Universidad de Navarra

Dr. Eduardo Castañón Álvarez

Specialist in Medical Oncology.

Works at: Madrid headquarters
Be part of: Clínica Universidad de Navarra Cancer Center Clínica Universidad de Navarra
INDEX H 19

Professional career

Graduated in Medicine from the University of Navarra in 2009.

Medical Resident in Medical Oncology at the Clínica Universidad de Navarra from 2010 to 2015.

ESMO MORA Certification obtained in 2013.

PhD in Medicine from the University of Navarra in 2015.

Clinical Fellow in the Department of Therapeutic Innovation and Early Trials (DITEP) at the Gustave Roussy Institute under Professor JC Soria (2015–2017).

Master’s Degree in Biostatistics, Autonomous University of Barcelona (2016–2020).

Master’s Degree in Molecular Oncology, Rey Juan Carlos University, Madrid (2018–2019).

Master’s Degree in Big Data Science, University of Navarra (2021–2022).

RESEARCH AREAS

  • Principal Investigator in over 40 clinical trials and Subinvestigator in over 100 clinical trials.
  • Basic Science Research Itinerary (2004–2007) at the Center for Applied Medical Research, Pamplona (Supervisor: P. Fortes).
  • International PhD, October 2015: “Id1 and Id3 gene implications in liver metastatic spread in non–small cell lung cancer” at the Center for Applied Medical Research, Pamplona (Supervisor: I. Gil-Bazo).

AREAS OF INTEREST

  • Phase I clinical trials of targeted therapies and immunotherapy.
  • Design of early-phase clinical trials.

Activity

In teaching

  • Accredited as Associate Professor by ANECA in 2019.
  • Assistant Professor of Medical Oncology, University of Navarra (2012–2019).
  • Assistant Professor at the School of Nursing, University of Navarra (2012–2017).
  • Instructor at the MIR Academy, Oviedo (2009–2019).

In research

  • Has presented more than 70 papers at national and international conferences, co-authored 8 educational books for residents and medical students, and contributed to over 50 publications in international journals.